Prosecution Insights
Last updated: July 17, 2026
Application No. 18/858,082

SYSTEMS AND METHODS FOR POSITIONING MEDICAL INSTRUMENTS

Non-Final OA §102
Filed
Oct 18, 2024
Priority
Apr 20, 2022 — provisional 63/332,918 +1 more
Examiner
HOLLM, JONATHAN ADAM
Art Unit
Tech Center
Assignee
Intuitive Surgical Operations Inc.
OA Round
1 (Non-Final)
49%
Grant Probability
Moderate
1-2
OA Rounds
2y 6m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 49% of resolved cases
49%
Career Allowance Rate
259 granted / 527 resolved
-10.9% vs TC avg
Strong +54% interview lift
Without
With
+54.5%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
31 currently pending
Career history
566
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
86.3%
+46.3% vs TC avg
§102
6.9%
-33.1% vs TC avg
§112
4.8%
-35.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 527 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Response to Amendment The Preliminary Amendment filed October 18, 2024 has been entered. Claims 1-19 and 21-28 are pending in the application. Information Disclosure Statement The information disclosure statements (IDS) submitted on October 24, 2024 and November 7, 2024 are in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statements are being considered by the examiner. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-19 and 21-28 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Pivotto et al. (U.S. Patent No. 9211130; hereinafter “Pivotto”) Regarding claim 1, Pivotto discloses a medical instrument comprising: a housing (242); an elongate member (282) axially fixed to and extending distally from the housing, the elongate member including a channel extending through the elongate member (col. 24, ll. 24-33); and a tool holder (232) moveably mounted to the housing and configured to accept and retain a tool (100) inserted through the tool holder and into the channel of the elongate member, wherein movement of the tool holder moves the tool relative to the elongate member (col. 24, ll. 38-40). Regarding claim 2, Pivotto discloses wherein the elongate member includes an articulable portion extending along at least a portion of a length of the elongate member (col. 38, ll. 23-26). Regarding claim 3, Pivotto discloses the instrument further comprising a tool actuator (160) disposed in the housing and configured to move the tool holder between a proximal position and a distal position to move the tool relative to the elongate member (col. 24, ll. 38-40). Regarding claim 4, Pivotto discloses the instrument further comprising a rocker arm (166) operatively coupling the tool actuator with the tool holder (Figs. 8-8A; col. 21, ln. 55 – col. 22, ln. 13). Regarding claim 5, Pivotto discloses the instrument further comprising an elongate member actuator (140; Fig. 3) configured to control the position of the elongate member (col. 21, ll. 24-41). Regarding claim 6, Pivotto discloses wherein the elongate member actuator is configured to control a position of the housing to control the position of the elongate member (col. 21, ll. 24-37). Regarding claim 7, Pivotto discloses the instrument further comprising at least one processor (control system includes at least one processor; col. 45, ll. 64 – col. 46, ln. 15) operatively coupled to the tool actuator (col. 24, ln. 64 – col. 25, ln. 16) and the elongate member actuator (col. 21, ll. 36-37), wherein the at least one processor is configured to control the tool actuator to control movement of the tool and to control movement of the elongate member actuator to control movement of the elongate member (col. 38, ln.62 – col. 39, ln. 63). Regarding claim 8, Pivotto discloses wherein: the elongate member includes a sensor (col. 27, ll. 22-34; col. 32, ll. 32-43) configured to detect movement of a distal tip of the elongate member (as part of the control of a steerable introducer; col. 28, ln. 38 – col. 29, ln. 27); and the at least one processor is configured to, in response to detecting movement of the distal tip of the elongate member using the sensor, control the tool actuator to move the tool relative to the elongate member (col. 47, ln. 55 – col. 49, ln. 15). Regarding claim 9, Pivotto discloses wherein the at least one processor is configured to control the tool actuator (col. 24, ln. 64 – col. 25, ln. 16) and the elongate member actuator (col. 21, ll. 36-37) to maintain a position of a distal portion of the tool during a relative movement of the tool and the elongate member that exposes the distal portion of the tool (col. 28, ln. 38 – col. 29, ln. 27; col. 38, ll. 23-26). Regarding claim 10, Pivotto discloses wherein the at least one processor is configured to maintain a pose of a distal portion of the tool during a relative movement of the tool and the elongate member that exposes a distal portion of the tool (col. 47, ln. 55 – col. 49, ln. 15). Regarding claim 11, Pivotto discloses wherein: the tool is an ablation tool (col. 22, ln. 32-44); and at least one processor is configured to control the ablation tool to treat a target tissue after a relative movement of the tool and the elongate member that exposes a distal portion of the ablation tool (col. 49, ll. 16-27). Regarding claim 12, Pivotto discloses the instrument further comprising: a first seal (224) disposed between a portion of the tool holder and a portion of the housing (col. 23, ll. 36-; and a second seal (214) disposed between the elongate member and the tool holder (col. 42, ln. 64 – col. 43, ln. 8). Regarding claim 13, Pivotto discloses wherein the tool holder is configured to translate relative to the housing and the elongate member (col. 21, ll. 51-54; col. 24, ll. 38-42). Regarding claim 14, Pivotto discloses wherein the tool holder is configured to rotate relative to the housing and the elongate member (col. 24, ll. 42-44). Regarding claim 15, Pivotto discloses a method for controlling movement of a medical instrument (Pivotto discloses methods of controlling movement throughout its disclosure, such as at col. 28, ln. 38 – col. 29, ln. 27; or at col. 47, ln. 55 – col. 49, ln. 15), the method comprising: positioning and retaining a tool (100) in a tool holder (232) moveably mounted to a housing (242), wherein the tool extends into a channel extending through an elongate member of the medical instrument (col. 24, ll. 24-33); and moving the tool holder relative to the housing while maintaining an axial position of the elongate member relative to the housing to move the tool relative to the elongate member (col. 24, ll. 38-40; see also col. 29, ll. 20-27). Regarding claim 16, Pivotto discloses the method further comprising articulating at least a portion of a length of the elongate member (col. 28, ln. 38 – col. 29, ln. 27). Regarding claim 17, Pivotto discloses the method further comprising moving the tool holder between a proximal position and a distal position via a tool actuator (160) disposed in the housing to move the tool relative to the elongate member (col. 24, ll. 38-40). Regarding claim 18, Pivotto discloses the method further comprising coupling the tool actuator with the tool holder via a rocker arm (166; Figs. 8-8A; col. 21, ln. 55 – col. 22, ln. 13). Regarding claim 19, Pivotto discloses the method further comprising controlling one selected from a group consisting of: the position of the elongate member via an elongate member actuator (140; Fig. 3; col. 21, ll. 24-41), and a position of the housing to control the position of the elongate member via the elongate member actuator (col. 21, ll. 24-37). Regarding claim 21, Pivotto discloses the method further comprising controlling the tool actuator to control movement of the tool and controlling the elongate member actuator to control movement of the elongate member (col. 38, ln.62 – col. 39, ln. 63). Regarding claim 22, Pivotto discloses the method further comprising: detecting movement of a distal tip of the elongate member (col. 28, ln. 38 – col. 29, ln. 27) via a sensor (col. 27, ll. 22-34; col. 32, ll. 32-43); and controlling the tool actuator to move the tool relative to the elongate member in response to detecting movement of the distal tip of the elongate member (col. 47, ln. 55 – col. 49, ln. 15). Regarding claim 23, Pivotto discloses the method further comprising controlling the tool actuator (col. 24, ln. 64 – col. 25, ln. 16) and the elongate member actuator (col. 21, ll. 36-37) to maintain a position of a distal portion of the tool during a relative movement of the tool and the elongate member that exposes the distal portion of the tool (col. 28, ln. 38 – col. 29, ln. 27; col. 38, ll. 23-26). Regarding claim 24, Pivotto discloses the method further comprising maintaining a pose of a distal portion of the tool during a relative movement of the tool and the elongate member that exposes a distal portion of the tool (col. 47, ln. 55 – col. 49, ln. 15). Regarding claim 25, Pivotto discloses wherein the tool is an ablation tool (col. 22, ln. 32-44), and further comprising controlling the ablation tool to treat a target tissue after a relative movement of the tool and the elongate member that exposes a distal portion of the ablation tool (col. 49, ll. 16-27). Regarding claim 26, Pivotto discloses the method further comprising translating the tool holder relative to the housing and the elongate member (col. 24, ll. 38-42). Regarding claim 27, Pivotto discloses the method further comprising rotating the tool holder relative to the housing and the elongate member (col. 24, ll. 42-44). Regarding claim 28, Pivotto discloses a medical instrument comprising: a housing (242); an elongate member (282) axially fixed to and extending distally from the housing, the elongate member including a channel extending through the elongate member (col. 24, ll. 24-33); and a tool holder (232) moveably mounted to the housing and configured to accept and retain a tool (100) inserted through the tool holder and into the channel of the elongate member, wherein the tool holder is configured to rotate relative to the housing and the elongate member and rotation of the tool holder rotates the tool relative to the elongate member (col. 24, ll. 42-44). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Jonathan A Hollm whose telephone number is (703)756-1514. The examiner can normally be reached Mon - Fri 8:30-5:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at (571) 272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JONATHAN A HOLLM/Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Oct 18, 2024
Application Filed
Jun 29, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12653560
ELECTRODE DESIGN FOR DIRECTIONAL LITHOTRIPSY CATHETERS
3y 6m to grant Granted Jun 16, 2026
Patent 12642545
BURST MODE OPERATION OF INTRAVASCULAR LITHOTRIPSY (IVL)
2y 3m to grant Granted Jun 02, 2026
Patent 12629165
FORCEPS CONSTRUCTION, SURGICAL INSTRUMENT AND SURGICAL INSTRUMENT COMPRISING SUCH FORCEPS CONSTRUCTION
5y 0m to grant Granted May 19, 2026
Patent 12616483
DEVICE AND METHOD FOR PERFORATING A DENSE BONE LAYER
5y 1m to grant Granted May 05, 2026
Patent 12599394
SURGICAL INSTRUMENT WITH A HANDLE
2y 11m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
49%
Grant Probability
99%
With Interview (+54.5%)
4y 3m (~2y 6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 527 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month